ARTICLE | Company News
BC Platforms, Pfizer advance genomic research on cardiovascular disease
February 16, 2018 8:02 PM UTC
BC Platforms (Basel, Switzerland) will analyze for Pfizer Inc. (NYSE:PFE) anonymized data from Turku University Hospital and other health care providers to generate real-world evidence in atrial fibrillation (AF) patients. BC Platform will use its genomic and clinical data management solutions, including its BCRQUEST.COM online portal. Microsoft Corp. (NASDAQ:MSFT) will provide its Azure cloud platform to analyze, index and access the data globally...